Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Clinical trial NCT04624113 · TERMINATED
Trial details
- NCT number
- NCT04624113
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-08-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.